Well Health Technologies announced that its subsidiary, Wellstar Technologies, has raised $62 million in financing to support its pre-spinout growth strategy. According to the company, the funding is intended to accelerate Wellstar’s product development, strengthen its balance sheet, and position it for long-term growth as it prepares for a potential public listing.
The company said that the financing consists of both equity and debt instruments, structured to provide capital flexibility and reduce near-term dilution. Wellstar focuses on developing and deploying digital health and artificial intelligence technologies aimed at improving patient care and clinical outcomes.
According to Well, the investment will be used to expand Wellstar’s engineering capabilities, scale its software and AI platforms, and enhance its presence in key international markets. The company claims the funding will also enable continued innovation across its technology ecosystem, supporting digital transformation initiatives in healthcare delivery.
Wellstar’s pre-spinout strategy, the company said, is designed to unlock shareholder value and establish the subsidiary as a standalone leader in healthcare technology. The company also noted that the financing aligns with its broader plan to optimize the capital structure across its operating divisions while maintaining strategic focus on growth and innovation.
Well stated that it expects the financing to help Wellstar accelerate product launches, pursue new partnerships, and advance toward operational independence as it builds momentum for its anticipated market debut.
